Table 5.
Descriptive statistics for the deep FAZ (%) in the study participants by selected clinical conditions (n = 28).
| Investigated Trait | Statistical Parameter | p-Value | |
|---|---|---|---|
| M (SD) | Me (Q1–Q3) | ||
| Localized scleroderma | 0.237 (0.171) | 0.190 (0.125–0.240) | =0.9996 |
| Systemic scleroderma | 0.237 (0.152) | 0.180 (0.110–0.370) | |
| Scleroderma pattern: | =0.0076 | ||
| ● Early | 0.456 (0.142) | 0.425 (0.345–0.555) | |
| ● Active | 0.197 (0.119) | 0.160 (0.110–0.260) | |
| ● Late * | 0.173 (0.132) | 0.110 (0.100–0.330) | |
| SCI70 | 0.243 (0.163) | 0.180 (0.100–0.390) | =0.9997 |
| Centromere | 0.237 (0.171) | 0.190 (0.125–0.240) | |
| Number of vessels: | =0.1350 | ||
| ● Normal | 0.435 (0.252) | 0.410 (0.220–0.650) | |
| ● Reduced | 0.227 (0.140) | 0.185 (0.110–0.335) | |
| ● Very reduced | 0.182 (0.114) | 0.120 (0.110–0.290) | |
| Avascular areas: | =0.2698 | ||
| ● Yes | 0.214 (0.138) | 0.120 (0.105–0.350) | |
| ● No | 0.263 (0.177) | 0.190 (0.150–0.260) | |
| Giant capillaries: | =0.2396 | ||
| ● Yes | 0.210 (0.120) | 0.180 (0.120–0.290) | |
| ● No | 0.262 (0.185) | 0.210 (0.110–0.390) | |
| Hemorrhages: | =0.0152 | ||
| ● Yes | 0.174 (0.079) | 0.160 (0.115–0.240) | |
| ● No | 0.271 (0.179) | 0.220 (0.110–0.390) | |
| Branched vessels: | =0.4219 | ||
| ● Yes | 0.267 (0.135) | 0.300 (0.150–0.390) | |
| ● No | 0.225 (0.166) | 0.180 (0.110–0.275) | |
| Interstitial lung disease: | =0.3505 | ||
| ● Yes | 0.270 (0.150) | 0.315 (0.100–0.390) | |
| ● No | 0.222 (0.160) | 0.170 (0.110–0.260) | |
| NSIP | 0.324 (0.142) | 0.370 (0.330–0.390) | =0.0484 |
| UIP | 0.140 (0.112) | 0.110 (0.070–0.210) | |
| MMF | 0.247 (0.147) | 0.190 (0.120–0.390) | =0.3844 |
| MTX | 0.193 (0.109) | 0.190 (0.110–0.220) | |
| Finger ulcers: | =0.3582 | ||
| ● Yes | 0.207 (0.129) | 0.135 (0.110–0.330) | |
| ● No | 0.249 (0.171) | 0.190 (0.110–0.370) | |
| Arterial hypertension: | =0.2474 | ||
| ● Yes | 0.195 (0.119) | 0.150 (0.120–0.260) | |
| ● No | 0.251 (0.171) | 0.190 (0.110–0.370) | |
| Administration of sildenafil: | =0.0222 | ||
| ● Yes | 0.181 (0.125) | 0.115 (0.100–0.300) | |
| ● No | 0.279 (0.173) | 0.210 (0.150–0.420) | |
| Administration of amlodipine: | =0.0780 | ||
| ● Yes | 0.278 (0.177) | 0.210 (0.120–0.390) | |
| ● No | 0.200 (0.137) | 0.140 (0.100–0.300) | |
M—mean; SD—standard deviation; Me—median; Q—quartile. * Scleroderma pattern, post-hoc multiple comparisons: early vs. active p < 0.0001; early vs. late p < 0.0001; active vs. late NS. Bold values indicate statistical significance.